Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

This roundup captures major judicial pronouncements and regulatory circulars released during the week. The key takeaway is enhanced clarity on deductions, GST powers, insolvency clean-slate principles ...